Literature DB >> 10555226

[Comparison of the quality of life of patients treated by surgery or radiotherapy in epidermoid cancer of the penis].

V Ficarra1, A Mofferdin, A D'Amico, G Zanon, D Schiavone, G Malossini, G Mobilio.   

Abstract

OBJECTIVE: The purpose of our work is to examine how partially or totally radical surgery and radiotherapy can weigh on quality of life in patients with squamous carcinoma of the penis, considering whether quality of life can be a good criterion in treatment options.
MATERIAL AND METHODS: We have interviewed 17 patients alive and disease-free (average follow-up 69.43 months) after surgical treatment or radiotherapy for cancer of the penis (emasculation, 2; total amputation of the penis, 2; partial penectomy, 11; radiotherapy, 2). Tests used: General Health Questionnaire (G.H.Q.-12 by D. Goldberg); Hospital Anxiety and Depression Scale (H.A.D.S.); Social Problem Questionnaire (S.P.Q.); Overall Sexual Functioning Questionnaire (O.S.F.Q); Family APGAR Questionnaire (F.A.Q.); Performance Status ECOG.
RESULTS: Thirty-five per cent of the patients presented limitations in their state of health and social problems. Anxiety was evident in 29.5% of the patients and depression in 6%. The global sexual function was compromised in 76.5%.
CONCLUSION: The profile of quality of life resulted compromised in the patients who had undergone radical surgical treatment. The sexual function was the most altered component. The impact of the pathology and its treatment on the other domains of quality of life proved less significant.

Entities:  

Mesh:

Year:  1999        PMID: 10555226

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  9 in total

1.  Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma.

Authors:  Vincenzo Ficarra; Giovanni Novella; Alessandra Sarti; Giacomo Novara; Antonio Galfano; Stefano Cavalleri; Walter Artibani
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Sexuality in Surgically Treated Carcinoma Penis Patients and Their Partners.

Authors:  Gajanan S Bhat; Girish Nelivigi; Vijayakumar Barude; Anuradha Shastry
Journal:  Indian J Surg       Date:  2016-08-20       Impact factor: 0.656

3.  Dyadic Aspects of Sexual Well-Being in Men with Laser-Treated Penile Carcinoma.

Authors:  Elisabet Skeppner; Kerstin Fugl-Meyer
Journal:  Sex Med       Date:  2015-06       Impact factor: 2.491

4.  Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma.

Authors:  Gaetano Gulino; Francesco Sasso; Giuseppe Palermo; Alfonso D'Onofrio; Marco Racioppi; Emilio Sacco; Francesco Pinto; Michele Antonucci; Alessandro D'Addessi; Pierfrancesco Bassi
Journal:  Indian J Urol       Date:  2013-04

5.  Evaluation of sexual functions and sexual behaviors after penile brachytherapy in men treated for penile carcinoma.

Authors:  Patrice Njomnang Soh; Boris Delaunay; Elie Bou Nasr; Martine Delannes; Michel Soulie; Eric Huyghe
Journal:  Basic Clin Androl       Date:  2014-08-28

6.  Quality of life in penile carcinoma patients - post-total penectomy.

Authors:  Roman Sosnowski; Marta Kulpa; Mariola Kosowicz; Jan Karol Wolski; Olga Kuczkiewicz; Katarzyna Moskal; Michał Szymański; Tomasz Kalinowski; Tomasz Demkow
Journal:  Cent European J Urol       Date:  2016-06-20

7.  Penile necrosis secondary to purpura fulminans: a case report and review of literature.

Authors:  David B Hogarth; Paul M Cheon; Javeed Kassam; Alexander E Seal; Alexander G Kavanagh
Journal:  J Surg Case Rep       Date:  2017-05-02

Review 8.  Psychosocial impact of penile carcinoma.

Authors:  François Audenet; John P Sfakianos
Journal:  Transl Androl Urol       Date:  2017-10

9.  Effects of partial penectomy for penile cancer on sexual function: A systematic review.

Authors:  Eleanor Whyte; Alexandra Sutcliffe; Philip Keegan; Tom Clifford; Jamie Matu; Oliver M Shannon; Alex Griffiths
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.